We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ZBIO market cap is 408.3M. The company's latest EPS is USD -0.8883 and P/E is -11.02.
| Quarter End | Sep 2024 | |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | |
| Operating Income | -40.99M | |
| Net Income | -38.61M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 50M |
| Operating Income | -76.2M | -37.15M |
| Net Income | -119.28M | -37.12M |
| Quarter End | Sep 2024 | |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 403.43M | |
| Total Liabilities | 44M | |
| Total Equity | 359.44M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 74.58M | 68.18M |
| Total Liabilities | 26.78M | 43.82M |
| Total Equity | -192.29M | -225.72M |
| Market Cap | 408.3M |
| Price to Earnings Ratio | -11.02 |
| Price to Sales Ratio | 8.18 |
| Price to Cash Ratio | 7.2 |
| Price to Book Ratio | 16.79 |
| Dividend Yield | - |
| Shares Outstanding | 41.79M |
| Average Volume (1 week) | 259.64k |
| Average Volume (1 Month) | 504.08k |
| 52 Week Change | -2.50% |
| 52 Week High | 26.11 |
| 52 Week Low | 7.79 |
| Spread (Intraday) | 0.83 (8%) |
| Company Name | Zenas BioPharma Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
